McKinney Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
McKinney Capital Management's BMY Position: Q2 2026 in Review
McKinney Capital Management increased its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, buying an estimated $151K and bringing the position to 22,523 shares worth $1.3M. The position accounts for 0.51% of the portfolio, ranked #43.
McKinney Capital Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,505 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- McKinney Capital Management held 22,523 shares of Bristol-Myers Squibb worth $1.3M as of Q2 2026.
- McKinney Capital Management bought 2,624 Bristol-Myers Squibb shares in Q2 2026, an estimated $151K.
- Bristol-Myers Squibb made up 0.51% of McKinney Capital Management's portfolio in Q2 2026, its #43 holding.
- McKinney Capital Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- 2,505 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on McKinney Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.